-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES THE FILING OF PROVISIONAL PATENT FOR NOVEL STRATEGY, SUPPORTED BY PRECLINICAL DATA, TO PREVENT METASTATIC RECURRENCE IN TRIPLE-NEGATIVE BREAST CANCER

Reuters·07/28/2026 11:30:15

Please log in to view news